“Not a Straightforward Decision”: What to Do While Waiting on a Practice Change in Breast Cancer Care
In the wake of recent key data about ESR1-mutated metastatic breast cancer, treatment decisions have become more complicated. “In current clinical practice, this is not a straightforward decision,” Marla Lipsyc-Sharf, MD, explains to Robert A. Figlin, MD.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from Oncology News Central Peer-Spectives
Is It Time for a New Type of Cancer Physician?
What the “Tsunami” of Cancer Survivors Means for Oncologists
“Sobering” Takeaway From ASCO 2026: Concerns About Clinical Trial Participation
“A Lot More Asymptomatic Cancer Out There”: Major MCED Trial Hints at Complicated Future
Get summaries like this every morning.
Free AI-powered recaps of Oncology News Central Peer-Spectives and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.